TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-/SMAD pathway

Objective: To investigate regulatory function and underlying mechanism of TRIM66 in non-small cell lung cancer (NSCLC). Methods: TRIM66 and MMP9 expression in NSCLC cells and tissues was assayed via qRT-PCR and western blot. CCK-8, colony formation, Transwell and flow cytometry assays were conducted to measure cell functional al-ternations in NSCLC. Western blot was employed to measure expression as well as phosphorylation levels of epithelial-mesenchymal transition-(EMT) and TGF-beta/SMAD pathways-related proteins. Co-immunoprecipitation (Co-IP) assay was done to probe interaction between TRIM66 and MMP9. Xenograft in vivo experiment and tumor metastasis model in nude mice were utilized to investigate effects of TRIM66 on tumor growth of NSCLC. Results: TRIM66 and MMP9 were conspicuously highly expressed in NSCLC cells and tissues. High TRIM66 level was markedly correlated with metastasis. Silencing TRIM66 prominently repressed the proliferation, migration and invasion of transfected cells, while inducing cell apoptosis. Whereas forced expression of TRIM66 exerted the opposite effect. The aberrant expression of TRIM66 modulated EMT pathway. TRIM66 also regulated MMP9 expression, and the interaction between them was validated by Co-IP assay. Overexpression of MMP9 could activate TGF-beta/SMAD pathway. Rescue experiments manifested that si-MMP9 or SB431542 could partially reverse phenotypes induced by TRIM66. In vivo experiments revealed that silencing TRIM66 could hamper NSCLC tumor growth and metastasis. Conclusion: TRIM66 and MMP9 were up-regulated in NSCLC. TRIM66 facilitated the malignant progression of NSCLC through modulating MMP9-mediated TGF-beta/SMAD pathway.

Automated summary

This study investigated the regulatory function and underlying mechanism of TRIM66 in non-small cell lung cancer (NSCLC). The results showed that TRIM66 and MMP9 were highly expressed in NSCLC cells and tissues, and the high level of TRIM66 was correlated with metastasis. Silencing TRIM66 inhibited proliferation, migration, and invasion of NSCLC cells, while forced expression of TRIM66 had the opposite effect. TRIM66 regulated the expression of MMP9 and modulated the TGF-beta/SMAD pathway, thereby facilitating the malignant progression of NSCLC.